hDcp1a Activators
The hDcp1a Activators are a class of chemical compounds that can indirectly influence the activity of hDcp1a by modulating the cellular processes and pathways in which hDcp1a is involved. For example, MG132 and Geldanamycin can influence protein levels by inhibiting the proteasome or Hsp90, respectively. This can indirectly influence the activity of hDcp1a, as the pool of proteins available in the cell for various processes, including mRNA decapping, can be altered.
Compounds like Actinomycin D, Cycloheximide, Puromycin, and Emetine affect RNA synthesis or protein biosynthesis, which can indirectly affect hDcp1a activity by influencing the pool of mRNAs available for decapping. Leptomycin B alters the subcellular localization of proteins, and can thereby indirectly influence hDcp1a and the mRNA decapping process. Rapamycin and LY294002 are inhibitors of mTOR and PI3K, respectively, which are involved in protein synthesis and cell growth. By influencing these processes, these compounds can indirectly affect hDcp1a. Resveratatrol is a modulator of several signaling pathways, which could indirectly affect hDcp1a activity. Lastly, SB203580 and SP600125, inhibitors of p38 MAPK and JNK, respectively, can influence stress responses that impact mRNA decay, indirectly affecting hDcp1a. These compounds do not directly activate hDcp1a, but rather, they influence the cellular processes and pathways that hDcp1a is involved in. This can lead to changes in hDcp1a activity, although the specific effects can be context-dependent and influenced by other factors in the cellular environment.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can prevent the degradation of proteins, including those involved in mRNA decapping. By stabilizing the protein levels in the cell, MG132 can indirectly influence the activity of proteins like hDcp1a. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D is a DNA intercalator that inhibits RNA synthesis. By blocking transcription, it indirectly affects mRNA turnover and could impact hDcp1a's activity. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide is a potent inhibitor of protein biosynthesis in eukaryotes. It binds to the ribosome and inhibits the translocation step in protein synthesis, thus potentially affecting hDcp1a indirectly by influencing the pool of mRNAs available for decapping. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B inhibits nuclear export of proteins. By altering the subcellular localization of proteins, it can indirectly affect hDcp1a and the mRNA decapping process. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an inhibitor of mTOR, a serine/threonine protein kinase involved in protein synthesis and cell growth. By inhibiting mTOR, it could indirectly influence hDcp1a by reducing the rate of protein synthesis and thereby potentially influencing mRNA turnover. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that affects a variety of cellular processes, including protein synthesis. Given the role of hDcp1a in mRNA turnover and translation control, this compound can indirectly affect hDcp1a. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is a natural phenol known to modulate several signaling pathways, including those involving protein synthesis and degradation. This could indirectly affect the activity of hDcp1a. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin is an Hsp90 inhibitor. As Hsp90 is involved in protein folding and stability, its inhibition could indirectly affect the stability and function of proteins involved in mRNA decapping, such as hDcp1a. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Puromycin is an aminonucleoside antibiotic that causes premature chain termination during translation. By influencing protein synthesis, it can indirectly affect hDcp1a. | ||||||
Emetine | 483-18-1 | sc-470668 sc-470668A sc-470668B sc-470668C | 1 mg 10 mg 50 mg 100 mg | $440.00 $900.00 $1400.00 $2502.00 | ||
Emetine is a protein synthesis inhibitor. By affecting the pool of mRNAs available for decapping, it can indirectly influence hDcp1a activity. | ||||||